Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.2650
0.00 (0.00%)
At close: May 6, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 1.06 million as of May 8, 2026. Its market cap has decreased by -48.62% in one year.
Market Cap
1.06M
Enterprise Value
384.77K
Revenue
n/a
Ranking
n/a
PE Ratio
1.44
Stock Price
0.27
Market Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 1.06M, an increase of 984.43%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.06M | 82.76% |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Doseology Sciences | 3.28M |
| BioVaxys Technology | 3.09M |
| Rakovina Therapeutics | 2.75M |
| Cytophage Technologies | 2.71M |
| Appili Therapeutics | 1.99M |
| Universal Ibogaine | 1.56M |
| ASEP Medical Holdings | 1.45M |
| Entheon Biomedical | 1.39M |